PC
AMGN icon

PointState Capital’s Amgen AMGN Stock Holding History

PointState Capital’s Portfolio AMGN Stock Details AMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-63,517
Closed -$19.8M – 55
2024
Q2 		$19.8M Buy
+63,517
New +$18.7M 0.43% 43
2022
Q3 		– Sell
-11,815
Closed -$2.88M – 49
2022
Q2 		$2.88M Buy
+11,815
New +$2.9M 0.07% 48
2014
Q3 		– Sell
-600,000
Closed -$71M – 104
2014
Q2 		$71M Buy
+600,000
New +$69.5M 0.89% 26
2013
Q4 		– Sell
-835,300
Closed -$93.5M – 143
2013
Q3 		$93.5M Buy
+835,300
New +$90.6M 1.6% 17

Other funds holding AMGN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM

PointState Capital's AMGN Position: Q3 2024 in Review

PointState Capital sold out of Amgen (AMGN) in Q3 2024, closing a stake of 63,517 shares — an estimated $19.8M sold.

PointState Capital first reported a position in AMGN in Q3 2013 and held it in 4 quarters. The position peaked at $93.5M in Q3 2013. 2,823 funds tracked by Wall St. Rank hold AMGN as of Q3 2024.

  • PointState Capital reported no remaining Amgen position as of Q3 2024 after selling out during the quarter.
  • PointState Capital sold 63,517 Amgen shares in Q3 2024, an estimated $19.8M.
  • PointState Capital first reported a position in Amgen in Q3 2013 and held it in 4 quarters.
  • PointState Capital's Amgen position peaked at $93.5M in Q3 2013.
  • 2,823 funds tracked by Wall St. Rank held Amgen as of Q3 2024.

Based on PointState Capital's 13F filing for Q3 2024, filed 14 Nov 2024.